Clinical trial
Vielight Neuro RX Gamma Photobiomodulation Device for Moderate to Severe Alzheimer's Disease
NCT03484143 is registered in ClinicalTrials.gov with Vielight Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vielight Neuro RX Gamma Photobiomodulation Device for Moderate to Severe Alzheimer's Disease
- Lead sponsor
- Vielight Inc.
- Phase
- Not applicable
- Overall status
- Suspended
- Start date
- June 26, 2019
- Completion date
- May 31, 2023
- Enrollment
- 228 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.